The United States Patent and Trademark Office (USPTO) just granted our patent that protects LIM109 and its uses in inflammatory and neurodegenerative diseases. This is an important step in our IP strategy since the USA market is one of the most important ones in the world.
Second Limnopharma US Patent granted
